Dermatology Devices Market Size, and Market Forecast – 2029

1. Dermatology Devices Market Size, and Market Forecast – 2029 Dermatology Devices Market in the World Size, Share, Outlook, and Opportunity Analysis, 2022- 2029, by Diagnostic Device (Imaging Device, Dermatoscope, Microscope), Treatment Device (Electrosurgical, Cryotherapy, Laser), Application (Skin Cancer Diagnosis, Acne, Psoriasis, Skin Rejuvenation, Warts), and Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa). Overview of the Market During the forecasting period, the global "Dermatology Devices Market" is expected to grow at a high CAGR of 12.20 % (2022-2029). Dermatology devices are aids for physicians and non-physician clinicians that are installed in hospitals and dermatology clinics. It aids in the treatment of skin diseases as well as cosmetic issues with the skin, scalp, hair, and nails. Due to an increase in skin disorders such as psoriasis, acne, melanoma, and others, there is a growing demand for dermatology devices. Download Free Sample: https://www.datamintelligence.com/download-sample/dermatology- devices-market Market Trends The global dermatology devices market is expected to grow due to an increase in the prevalence of diseases that require surgical treatment, particularly minimally invasive surgery (MIS), which will aid the market's growth during the forecast period. In the forecast period, the rising incidence of skin disorders will drive market growth. Because of the rising prevalence of skin cancer and other skin diseases, the dermatology devices market is expected to grow rapidly, contributing significantly to the high demand for dermatology devices. Furthermore, the adoption of these devices is fueled by rising awareness of cosmetic procedures to improve aesthetic appeal and technological advancements in dermatology devices. The market for dermatology devices is being driven by an increase in disposable income. Skin disease, which affects millions of people around the world, is one of the leading causes of the rising global disease burden. A variety of skin diseases develop as a result of ageing, environmental, and genetic factors. Melanoma and non-melanoma skin cancers are becoming increasingly common. Every day, approximately 9,500 people in the United States are diagnosed with skin cancer, according to the American Academy of Dermatology Association 2022. According to the American Cancer Society, approximately 99,780 new melanomas will be diagnosed in the United States in 2022, with approximately 7,650 people dying from melanoma in the same year. The market for treatment devices, aesthetic lasers, and cosmetic dermatology is being driven by the growing demand for aesthetic procedures. Hair removal, skin rejuvenation, acne, psoriasis, tattoo removal, wrinkle removal, skin resurfacing, vascular lesions, and pigmented lesions, among other skin diseases, are all treated with these lasers. Longer wavelengths and improved configurations of lasers have broadened the range of beauty treatments, making the aesthetic lasers industry profitable. The market for dermatology treatment devices is being pushed by the growing demand for aesthetic procedures. The market's growth will be hampered by the side effects of dermatological treatments.

2. However, side effects associated with dermatological treatments and strict regulatory policies for medical devices are two factors that are likely to stifle market growth. Skin rashes, itching, changes in hair texture, inflammation around the nails, and mouth blisters are all possible side effects of these treatments. COVID-19 Impact Assessment The COVID-19 pandemic had an impact on the dermatology device market. Global pharmaceutical and medical supply chains were severely hampered by the pandemic. During the forecast period, this is expected to limit the growth of the dermatology devices market. Increased awareness of the need to avoid hospital-acquired infections and the risk of being exposed to COVID-19 during the pandemic is expected to limit the number of surgical aesthetic procedures, lowering the dermatology devices market's growth during the forecast period. Non-urgent clinical procedures and surgical procedures must be postponed during the COVID-19 crisis until the situation improves. Hospitals must ensure that patients receive high-quality care. As a result, the dermatology devices industry has been severely impacted, with numerous losses. Even the R&D mission has come to a halt to some extent. Analysis of Segments During the forecast period, the dermatoscope segment is expected to grow at the fastest CAGR (2022-2029) A dermatoscope, also known as a skin surface microscope, is a non-invasive, handheld magnification tool that is placed directly on the patient's skin surface to examine the key morphological structures of skin lesions that are on and below the skin surface and are not visible to the naked eye. Dermatologists can use this to distinguish benign from malignant (cancerous) lesions, which is especially helpful in the diagnosis of melanoma. Dermoscopy has also been shown to improve dermatologists' diagnostic accuracy, sensitivity, and specificity when it comes to skin cancer diagnosis. These devices have remained valuable in the dermatology industry, and new technologies in areas such as artificial intelligence (AI) have enhanced their uses to the point where they have become an indispensable tool in every medical professional's office. They're also gaining traction in other areas of medicine, such as primary care. Dermatoscopes have been proven to be accurate in several studies. Furthermore, over the forecast period, the introduction of advanced dermatoscope is expected to drive product demand. HEINE, a global primary diagnostic instrument manufacturer, released two new dermatoscopes in 2020, the DELTA 30 and DELTA, one in the United States, with an enhanced achromatic optical system for pristine images. As a result, the aforementioned factors are expected to propel the dermatology devices market forward. Analyses by Location The dermatology devices market in the United States is dominated by the North American region. North America has taken the lead in terms of market share. Because of the rising prevalence of skin cancer and other skin diseases like eczema and rosacea, this trend is likely to continue. In the United States, there is an increasing number of skin cancer cases. According to the Skincare Foundation, one in every five Americans will develop skin cancer by the age of 70 in 2020. Every hour, more than two people in the United States die of skin cancer. Melanoma also has a 99 percent 5-year survival rate

3. when detected early. As a result, the rising incidence of skin cancer and other skin diseases plays a significantly to the high demand for dermatology devices. Several medical technology firms concentrate on developing products that are less expensive, faster, and more efficient for patients. Lancer Skincare will release its first skincare exfoliating device, the Pro Polish Microdermabrasion Device, in July 2020. By delivering surface-layer microdermabrasion in a patented, handheld device, Pro Polish improves the efficacy of the Lancer routine. These advancements in dermatology devices, in terms of features and broad application for skin diseases, are expected to drive dermatology device demand in the market. Competitive Environment The dermatology devices market is a moderately competitive market with both domestic and international players. Abbvie Inc. (Allergan Inc.), Alma Lasers Ltd, Bausch Health Companies Inc. (Solta Medical Inc.), Bruker Corporation, CANDELA CORPORATION, Carl Zeiss, Cutera Inc., Galderma SA, Genesis Biosystems Inc., Hologic Inc. (Cynosure Inc.), and others are among the key players contributing to the market's growth. Product launches, acquisitions, and collaborations are among the major players' growth strategies, all of which are contributing to the global growth of the Dermatology Devices Market. For example, Obagi, a science-based skincare company that has been a leader in professional skin care products for over 30 years, announced the official launch of its first device, the Skintrinsiq, in December 2021. its first entry into the complementary skincare device market. About Us DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world. For more information: Sai Kiran Sales Manager at DataM Intelligence Email: info@datamintelligence.com